Viral-based individualized neoantigen vaccine as adjuvant treatment in resected 2 head and neck squamous cell carcinoma: immunogenicity and efficacy from a 3 randomized Phase I trial
C. Ottensmeier, et al. medRxiv Prepublication disponible sur le site medRxiv – Télécharger l’ Article